proof
newli
identifi
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
primari
caus
sever
acut
respiratori
syndrom
sar
came
seri
studi
experiment
infect
cynomolgu
macaqu
macaca
fasciculari
sarscovinfect
macaqu
develop
diseas
compar
sar
human
viru
reisol
anim
develop
sarscovspecif
antibodi
complet
fulfil
koch
postul
modifi
river
viral
diseas
sarscov
aetiolog
agent
sar
besid
macaqu
model
ferret
cat
model
sarscov
also
develop
anim
model
allow
compar
pathogenesi
studi
sarscov
infect
test
differ
intervent
strategi
first
studi
shown
pegyl
drug
approv
human
use
limit
sarscov
replic
lung
damag
experiment
infect
macaqu
final
argu
given
worldwid
natur
socioeconom
chang
predispos
emerg
sar
avian
influenza
southeast
asia
chang
herald
begin
global
trend
ill
prepar
sar
emerg
year
ago
new
human
diseas
entiti
lee
et
al
result
death
document
probabl
case
diseas
six
month
diseas
first
recogn
declar
global
outbreak
control
sporad
case
diagnos
sinc
respons
start
outbreak
coordin
intern
collabor
includ
clinic
epidemiolog
laboratori
investig
control
expand
epidem
identif
caus
agent
one
first
research
prioriti
sever
virus
bacteria
initi
identifi
sar
patient
recent
identifi
hmpv
van
den
hoogen
et
al
newli
discov
human
coronaviru
sarscov
drosten
et
al
prove
like
candid
epidemiolog
ground
compar
studi
involv
patient
fit
sar
case
definit
cohort
asia
europ
hmpv
infect
diagnos
sarscov
infect
patient
respiratori
pathogen
identifi
sporad
sarscov
therefor
like
causal
agent
sar
kuiken
et
al
accord
koch
postul
modifi
river
viru
diseas
six
criteria
met
establish
viru
caus
diseas
first
three
name
isol
viru
diseas
host
cultiv
host
cell
proof
filter
met
hmpv
sarscov
remain
three
criteria
test
seri
experi
conduct
author
correspond
aosterhau
erasmusmcnl
cynomolgu
macaqu
macaca
fasciculari
product
compar
diseas
origin
host
speci
relat
one
reisol
viru
detect
specif
immunorespons
viru
kuiken
et
al
four
monkey
infect
sarscov
isol
vero
cell
patient
die
sar
hong
kong
three
becam
letharg
day
infect
onward
two
develop
temporari
skin
rash
day
infect
upon
necropsi
carri
day
infect
three
anim
multipl
foci
pulmonari
consolid
lung
histolog
main
lesion
consolid
lung
tissu
involv
alveoli
bronchiol
consist
area
acut
advanc
phase
diffus
alveolar
damag
occasion
multinucl
giant
cell
found
macaqu
without
clear
macroscop
pulmonari
lesion
minimum
multifoc
inflammatori
lesion
observ
histolog
pulmonari
tissu
immunohistochemistri
presenc
sarscov
could
demonstr
inflam
lung
tissu
three
macaqu
show
pulmonari
consolid
presenc
sarscov
lung
also
confirm
show
typic
coronaviruslik
particl
pneumocyt
affect
pulmonari
area
day
infect
onward
sarscov
could
isol
demonstr
revers
transcriptionpolymeras
chain
reaction
sputum
nasal
swab
pharyng
swab
one
anim
separ
macaqu
infect
experi
shown
sarscovneutr
antibodi
present
day
infect
onward
viru
also
isol
faec
one
two
monkey
involv
experi
relev
respiratori
pathogen
identifi
macaqu
experiment
infect
sarscov
collect
data
complet
six
criteria
need
fulfil
identifi
sarscov
aetiolog
agent
sar
probabl
spill
recent
anim
reservoir
moreov
lesion
macaqu
infect
experiment
hmpv
isol
nonsar
individu
limit
mild
suppur
rhiniti
minim
eros
conduct
airway
kuiken
et
al
kuiken
et
al
diseas
exacerb
two
sarscovinfect
macaqu
subsequ
inocul
hmpv
kuiken
et
al
besid
cynomolgu
macaqu
also
succeed
infect
ferret
domest
cat
experiment
sarscov
martina
et
al
viru
effici
transmit
noninfect
cage
mate
cat
develop
clinic
sign
wherea
ferret
becam
letharg
one
die
infect
respiratori
tract
evid
infect
anim
histolog
sarscov
infect
associ
pulmonari
lesion
similar
observ
sarscov
infect
macaqu
except
milder
particularli
cat
avail
three
anim
model
sarscov
infect
allow
us
carri
compar
pathogenesi
studi
well
test
differ
intervent
strategi
like
use
antivir
sarscovspecif
antibodi
candid
vaccin
current
use
ferret
macaqu
model
studi
recent
show
macaqu
model
prophylact
treatment
sarscovinfect
macaqu
antivir
agent
pegyl
drug
approv
human
usesignificantli
reduc
viral
replic
excret
well
pulmonari
damag
compar
untreat
macaqu
haagman
et
al
postexposur
treatment
drug
yield
intermedi
result
data
warrant
clinic
studi
drug
sar
reemerg
prophylact
earli
postexposur
treatment
pegyl
may
help
reduc
impact
sarscov
infect
healthcar
worker
other
possibl
expos
sarscov
may
limit
spread
viru
human
popul
final
one
may
wonder
whether
recent
emerg
sar
emerg
avian
influenza
outbreak
also
result
anim
human
transmiss
fatal
consequ
de
jong
et
al
claa
osterhau
webbi
webster
hien
et
al
southeast
asia
particularli
guandong
provinc
china
may
result
key
socioeconom
chang
region
kuiken
e
osterhau
unpublish
data
may
argu
given
worldwid
natur
chang
observ
increas
emerg
viru
infect
area
may
herald
begin
global
trend
ill
prepar
kuiken
et
al
kuiken
et
al
phil
tran
r
soc
lond
b
